Recent Advances in Managementof Prostate Cancer
Journal Title: Journal of Oncobiomarkers - Year 2017, Vol 3, Issue 1
Abstract
Prostate cancer is the second most common cancer in males worldwide and the incidence is increasing due to ageing population, screening facilities and rising awareness. This is a disease of the elderly and is biologically less aggressive as compared to some other malignancies. Most of the patients present with organ-confined disease, thus the age adjusted death rates are declining due to early detection and timely intervention. The various treatment options include external radiotherapy, brachytherapy or radical prostatectomy for low-risk early stage disease; hormonal therapy and external radiotherapy for advanced high-risk cases; and hormonal therapy, palliative radiotherapy with or without chemotherapy for metastatic disease. The main aim of this article is to sensitize the readers with the recent advances in management of cancer prostate.
Authors and Affiliations
Virender Suhag
Keywords
Related Articles
- EP ID EP245949
- DOI 10.13188/2325-2340.1000011
- Views 112
- Downloads 0
The Relative Fewness of Renal Metastases in Lung Cancer is Probably Explicable with the “Erythrocyte Associated Necrosis Factor” which may be an Oncobiomarker
There is profundity of lung cancer cells thrown into the circulation with each heart beat and the quantity of the quarter of the cardiac stroke volume being delivered to the kidneys. Despite both of these attractive attr...
Chemokine Receptors as Biomarkers in Head and Neck Squamous Cell Carcinoma
Head and neck squamous cell carcinoma (HNSCC) is reported to be the 6th most common solid tumor diagnosed in the world [1]. Around 95% head and neck cancers are squamous cell carcinomas originating in the upper aerod...
Recent Advances in Managementof Prostate Cancer
Prostate cancer is the second most common cancer in males worldwide and the incidence is increasing due to ageing population, screening facilities and rising awareness. This is a disease of the elderly and is biologicall...
Redefining the HER2 Oncobiomarker: A Relevant Case Report
In multiple studies anti HER2 therapy combined with chemotherapy demonstrated a marked improvement in disease free survival as adjuvant therapy and as treatment for metastatic breast cancer compared to chemotherapy alone...
Involvement of Sphingosine Kinases/Sphingosine-1-Phosphate (S1P)/S1P Receptors in Breast Cancer Subtypes
There is emerging evidence suggesting sphingolipids as critical regulators of cancer development and progression. Sphingolipids are potent bioactive lipids involved in fundamental biological processes including cell prol...